Nanographene oxide-based radioimmunoconstructs for in vivo targeting and SPECT imaging of HER2-positive tumors.

Nanographene oxide (NGO) is a novel nano-wall material that tracks to tumors in vivo, and which, as a consequence of its large surface area, has the capacity to carry a large payload. This study explores the use of anti-HER2 antibody (trastuzumab)-conjugated NGO, radiolabeled with (111)In-benzyl-die...

Бүрэн тодорхойлолт

Номзүйн дэлгэрэнгүй
Үндсэн зохиолчид: Cornelissen, B, Able, S, Kersemans, B, Waghorn, P, Myhra, S, Jurkshat, K, Crossley, A, Vallis, K
Формат: Journal article
Хэл сонгох:English
Хэвлэсэн: Elsevier 2013

Ижил төстэй зүйлс